Synapse - Dean Bajorin

Results (663)

Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States

Journal Article

Apolo, A. B.; Kim, J. W.; Bochner, B. H.; Steinberg, S. M.; Bajorin, D. F.; Kevin Kelly, W.; Agarwal, P. K.; Koppie, T. M.; Kaag, M. G.; Quinn, D. I.; more...
Urologic Oncology: Seminars and Original Investigations (2014)

Fulltext@MSK | Save

Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND

Meeting Abstract

Tully, C. M.; Bochner, B. H.; Dalbagni, G.; Zabor, E. C.; Herr, H. W.; Donat, S. M.; Ostrovnaya, I.; Regazzi, A. M.; Kim, P. H.; Sfakianos, J. P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis)

Meeting Abstract

Tully, C. M.; Apolo, A. B.; Zabor, E. C.; Regazzi, A. M.; Ostrovnaya, I.; Rosenberg, J. E.; Bajorin, D. F.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Impact of prior platinum agent and site of primary in patients with advanced urothelial carcinoma (UC) receiving salvage therapy

Meeting Abstract

Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Impact of number of lines of prior chemotherapy in patients (pts) with advanced urothelial carcinoma (UC) receiving salvage therapy

Meeting Abstract

Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Targeted sequencing of upper tract urothelial carcinoma

Meeting Abstract

Sfakianos, J. P.; Kim, P. H.; Iyer, G.; Cha, E. K.; Zabor, E. C.; Hakimi, A. A.; Scott, S. N.; Ramirez, R.; Hanrahan, A.; Rosenberg, J. E.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Clinical evaluation of cisplatin sensitivity germ line polymorphisms in neoadjuvant chemotherapy (NAC) for urothelial cancer (UC)

Meeting Abstract

O'Donnell, P. H.; Garcia-Grossman, I. R.; Cao, H. Y.; Ostrovnaya, I.; Plimack, E. R.; Stratton, K. L.; Manschreck, C.; Smith, N. D.; Steinberg, G. D.; Joseph, V.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Pilot investigation of variants in DNA repair pathways and association with response to platinum-based chemotherapy in bladder cancer

Meeting Abstract

Kopp, R. P.; Stratton, K. L.; Garcia-Grossman, I. R.; Zabor, E. C.; Ostrovnaya, I.; Thomas, T.; Gerber, G.; Alanee, S. R.; Schrader, K. A.; O'Donnell, P. H.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Using exon-capture, deep sequencing of high-grade bladder urothelial carcinoma to identify recurrent genetic alterations and potential therapeutic targets

Meeting Abstract

Kim, P. H.; Sfakianos, J. P.; Scott, S. N.; Iyer, G.; Cha, E. K.; Al-Ahmadie, H.; Sun, A. J.; Garcia-Grossman, I. R.; Bambury, R. M.; Dalbagni, G.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Branched evolution and intratumor heterogeneity of urothelial carcinoma of the bladder

Meeting Abstract

Cha, E. K.; Sfakianos, J. P.; Al-Ahmadie, H.; Scott, S. N.; Kim, P. H.; Iyer, G.; Bajorin, D. F.; Rosenberg, J. E.; Berger, M. F.; Bochner, B. H.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save